NYSEArca - Delayed Quote USD

KraneShares MSCI All China Health Care Index ETF (KURE)

14.90 -0.17 (-1.09%)
At close: November 15 at 12:49 PM EST

Top 10 Holdings (47.24% of Total Assets)

SymbolCompany% Assets
300760.SZ
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 8.22%
600276.SS
Jiangsu Hengrui Medicine Co., Ltd. 7.58%
6160.HK
BeiGene, Ltd. 6.54%
2269.HK
WuXi Biologics (Cayman) Inc. 4.49%
1093.HK
CSPC PHARMA 3.74%
600436.SS
Zhangzhou Pientzehuang Pharmaceutical., Ltd 3.60%
300015.SZ
Aier Eye Hospital Group Co., Ltd. 3.44%
603259.SS
WuXi AppTec Co., Ltd. 3.34%
1801.HK
INNOVENT BIO 3.30%
9926.HK
Akeso, Inc. 2.99%

Sector Weightings

Overall Portfolio Composition (%)

Stocks 99.74%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.05
Price/Book 0.36
Price/Sales 0.65
Price/Cashflow 0.06
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

ETF Overview

Category China Region
Fund Family KraneShares
Net Assets 43.32M
YTD Daily Total Return -7.80%
Yield 0.74%
Legal Type Exchange Traded Fund

Related Tickers